vimarsana.com
Home
Live Updates
Bio-Techne Celebrates 40,000 Unique RNAscope™ in situ
Bio-Techne Celebrates 40,000 Unique RNAscope™ in situ
Bio-Techne Celebrates 40,000 Unique RNAscope™ in situ Hybridization Probes, Targeting Any Gene, Any Tissue, Any Species.
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced Advanced Cell Diagnostics (ACD), a brand of Bio-Techne, reached an extraordinary...
Related Keywords
Kim Kelderman ,
David Clair ,
Prnewswire Bio Techne Corporation ,
Rnascope Technology ,
Investor Relations Corporate Development ,
Bio Techne Corporation ,
Techne Corporation ,
Advanced Cell Diagnostics ,
Integrated Co Detection Workflow ,
Senior Director ,
Investor Relations ,